Phase I and pharmacological study of AZD1152, a selective inhibitor of aurora kinase B
David S. Boss(The Netherlands Cancer Institute), P.O. Witteveen(University of Groningen), M. Mergui(The Netherlands Cancer Institute), J. van der Sar(The Netherlands Cancer Institute), Paul K. Stockman(AstraZeneca (Brazil)), Emile E. Voest(University of Groningen), Jos H. Beijnen(Slotervaartziekenhuis), Jan H.M. Schellens(The Netherlands Cancer Institute)
Data Archiving and Networked Services (DANS)
November 1, 2009
Cited by 0
Abstract
Related Papers
No related papers found
Powered by citation graph analysis